Many patients may keep off lost pounds after stopping a GLP-1, US data suggests
Real-world data suggests weight loss durability post-GLP-1 drug discontinuationStudy suggests weight regain may be less common than clinical…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…
BGI Genomics, Roche roll out diagnostic tests for Alzheimer’s in China
SHANGHAI, Jan 14 (Reuters) – BGI Genomics (300676.SZ), opens new tab and Roche Diagnostics (ROG.S), opens new tab…
US FDA requests removal of suicide warnings from weight-loss drug labels
Regulator asks drugmakers to remove warnings of suicidal thoughts from GLP-1 drugs’ labelsFDA finds no link between GLP-1…
J&J strikes deal with US government to cut drug prices, gain tariff exemptions
Jan 8 (Reuters) – Johnson & Johnson (JNJ.N), opens new tab said on Thursday that it has reached…
Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software
Jan 9 (Reuters) – Schrodinger (SDGR.O), opens new tab said on Friday it is collaborating with Eli Lilly…
Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump
Number of hikes rises from same time a year agoMedian list price increase is 4%, in line with…
US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Dec 30 (Reuters) – Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention…
European shares close at fresh record high as Novo Nordisk drives healthcare boost
Euro zone equity volatility at over a year-lowHealthcare stocks top gainers after Novo Nordisk boostBasic resources gain on…